This brand name is authorized in Estonia
The drug ALMINOX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Aluminum aminoacetate
UNII 5TLG1CL557 - ALUMINIUM TRIGLYCINATE
|
|
|
|
2
Magnesium oxide
UNII 3A3U0GI71G - MAGNESIUM OXIDE
|
|
Magnesium oxide (MgO), or magnesia, is an empirical formula of MgO and consists of a lattice of Mg2+ ions and O2− ions held together by ionic bonding. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1003891, 1129676 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
